Lamotrigine childhood overdose

Pediatric Neurology

Volumn 19, Issue 3, 1998, Pages 239-242

  Briassoulis, George ^a   Kalabalikis, Panajiotis ^a   Tamiolaki, Maria ^a   Hatzis, Tassos ^a  

^a Pediat Intensive Care U Aghia S   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; LAMOTRIGINE; MIDAZOLAM;

ARTICLE; ATAXIA; CASE REPORT; CHILD; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG OVERDOSE; FLUID THERAPY; HUMAN; MALE; MUSCLE HYPERTONIA; MUSCLE WEAKNESS; PRIORITY JOURNAL; STOMACH LAVAGE; TONIC CLONIC SEIZURE; TREMOR;

ANTICONVULSANTS; CHILD, PRESCHOOL; EPILEPSY, TONIC-CLONIC; GASTRIC LAVAGE; HUMANS; MALE; MIDAZOLAM; OVERDOSE; TREATMENT OUTCOME; TRIAZINES;

EID: 0032168009     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(98)00050-2     Document Type: Article

References (21)

1. Leach J.P., Brodie M.J. Lamotrigine: Clinical use. Levy R.H., Mattson R.H., Melldrum B.S. Antiepileptic Drugs. 4th ed. 1995;889-895 Lippincott, Raven, Philadelphia.
2. Brodie M.J., Richens A., Yuen A.W.C. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet. 345:1995;476-479.
3. Kilpatrick E.S., Forrest G., Brodie J.M. Concentration-effect and concentration-toxicity relations with lamotrigine A prospective study . Epilepsia. 37:1996;534-538.
4. Betts T., Goodwin G., Withers R.M., Yuen A.W.C. Human safety of lamotrigine. Epilepsia. 32:(Suppl 2):1991;17-21.
5. Burroughs Wellcome. 1995.
6. Glaxo Wellcome. Package insert.
7. Fazio A., Artezi C., Russo M., Trio R., Oteri G., Pisani F. A liquid chromatographic assay using a high speed column for determination of lamotrigine, a new antiepileptic drug, in human plasma. Ther Drug Monit. 14:1992;509-512.
8. Brodie M.J. Lamotrigine. Lancet. 339:1992;1397-1400.
9. Tomson T., Ohman I., Vitols S. Lamotrigine in pregnancy and lactation A case report . Epilepsia. 8:1997;1039-1041.
10. Ramsey R.E., Pellock J.M., Garnett W.R., et al. Pharmacokinetics and safety of lamotrigine (Lamictal) in patients with epilepsy. Epilepsy Res. 10:1991;191-200.
11. Matsuo F., Gay P., Madsen J., et al. Lamotrigine high-dose tolerability and safety in patients with epilepsy A double-blind, placebo-controlled, eleven-week study . Epilepsia. 37:1996;857-862.
12. Ayala R., Casale E.J., Brookins T.A., Manasco P. The effectiveness and safety of Lamictal (lamotrigine) monotherapy for the treatment of newly-diagnosed typical absence seizures in children and adolescents (Abstract). Epilepsia. 37:(Suppl 5):1996;165.
13. Sander J.W., Patsalos P.N., Oxley J.R., Hamilton M.J., Yuen W.C. A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy. Epilepsy Res. 6:1990;221-226.
14. Reunanen M., Dam M., Yuen A.W. A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy. Epilepsy Res. 23:1996;149-155.
15. Loscher W., Jackel R., Muller F. Anticonvulsant and proconvulsant effects of inhibitors of GABA degradation in the amygdala-kindling model. Eur J Pharmacol. 163:1989;1-14.
16. Hart Y.M., Meinardi H., Sander J.W.A.S., Nut D.J., Shorvon S.D. The effect of intravenous flumazenil on interictal electroencephalographic epileptic activity Results of a placebo-controlled study . J Neurol Neurosurg Psychiatry. 54:1991;305-309.
17. 3H] dihydropicrotoxinin binding sites at the benzodiazepine-GABA receptor-ionophore complex. Brain Res. 223:1981;218-222.
18. Sander J.W., Trevisol-Bittencourt P.C., Hart Y.M., Patsalos P.N., Shorvon S.D. The efficacy and long-term tolerability of lamotrigine in the treatment of severe epilepsy. Epilepsy Res. 7:1990;226-229.
19. Wallace S.J. Myoclonus and epilepsy in childhood A review of treatment with valproate, ethosuximide, lamotrigine and zonisamide . Epilepsy Res. 29:1998;147-154.
20. Xiong Z.Q., Stringer J.L. Effects of felbamate, gabapentin and lamotrigine on seizure parameters and excitability in the rat hippocampus. Epilepsy Res. 27:1997;187-194.
21. Veliskova J., Velisek L., Moshe S.L. Age-specific effects of baclofen on pentylenetetrazol-induced seizures in developing rats. Epilepsia. 37:1996;718-722.